FDA Boxed Warning: Clopidogrel (Plavix®) Clinical Alert

Updated:Jul 13,2015

FDA Boxed Warning: Clopidogrel (Plavix®) Clinical Alert

  • Clinical antiplatelet effectiveness is reduced for poor metabolizers of clopidogrel. 
  • Genetic tests are available to identify poor metabolizers.
  • Emerging role of genetic testing in clopidogrel treatment decisions


    Read full clinical alert in Circulation

Supporting Materials

Other AHA Statements on Anticoagulation


Professional Online Network

Connect with over 30,000 heart and stroke professionals.